Skip to content
10-K

Annual Report

Medicale Corp. MCLE

0001683168-24-000004

← back to feed
Filed
Jan 2, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Dec 15, 2023 5.92M sh
Shares Diluted FY 2023 · Sep 30, 2022 5.92M sh
Operating Cash Flow FY 2023 · Sep 30, 2022 −$24.62K
Current Liabilities FY 2023 · Sep 30, 2022 $54.77K
Current Assets FY 2023 · Sep 30, 2022 $0
Total Assets FY 2023 · Sep 30, 2022 $0
Eps Diluted FY 2023 · Sep 30, 2022 −$0.01
Eps Basic FY 2023 · Sep 30, 2022 −$0.01
Sga Expense restated FY 2023 · Sep 30, 2022 $44.02K
Net Income FY 2023 · Sep 30, 2022 −$46.42K
Operating Income restated FY 2023 · Sep 30, 2022 −$44.02K
Stockholders Equity FY 2023 · Sep 30, 2021 −$8.36K